PD-L1 as a prognostic biomarker in surgically resectable non-small cell lung cancer: a meta-analysis

BACKGROUND: PD-L1 tumor expression has been associated with poor prognosis in a variety of solid tumors, including lung cancer, and represents a validated target for immune checkpoint inhibition in advanced malignances. It remains unknown, however, if PD-L1 can be used to predict survival in early s...

Descripción completa

Detalles Bibliográficos
Autores principales: Tuminello, Stephanie, Sikavi, Daniel, Veluswamy, Rajwanth, Gamarra, Cesar, Lieberman-Cribbin, Wil, Flores, Raja, Taioli, Emanuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481631/
https://www.ncbi.nlm.nih.gov/pubmed/32953509
http://dx.doi.org/10.21037/tlcr-19-638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481631/
https://www.ncbi.nlm.nih.gov/pubmed/32953509
http://dx.doi.org/10.21037/tlcr-19-638

Ejemplares similares